Malignancy-associated Immunodeficiency
Malignancy-Associated Immunodeficiency is a secondary immunodeficiency characterized by impaired immune function resulting directly from the pathophysiological effects of malignant cells, their secreted products, or cancer-induced alterations in immune regulation.
243
Publications
13.8K
Citations
1.3K
Authors
438
Institutions
Publications per year
2017–2026
21
Parents
243
Gary M. Clifford, Jerry Polesel, Martin Rickenbach et al. · JNCI Journal of the National Cancer Institute · 2005 · 856 citations · Full text
Thomas S. Uldrick, Victoria Wang, Deirdre O’Mahony et al. · Clinical Infectious Diseases · 2010 · 313 citations · Full text
The epidemiology of acquired immunodeficiency syndrome malignancies.
JamesJ. Goedert · PubMed · 2000 · 287 citations
1–5 of 243
1.3K
6
h-index
5
h-index
5
h-index
5
h-index
4
h-index
1–5 of 1.3K
438
National Cancer Institute
Bethesda, United States
18 h-index
75 publications
11.2K citations
Memorial Sloan Kettering Cancer Center
New York, United States
10 h-index
29 publications
924 citations
Centro di Riferimento Oncologico
Aviano, Italy
8 h-index
25 publications
2K citations
National Institutes of Health
Bethesda, United States
8 h-index
46 publications
4.8K citations
University of California, San Francisco
San Francisco, United States
7 h-index
13 publications
982 citations
University of Southern California
Los Angeles, United States
6 h-index
20 publications
528 citations
Center for Cancer Research
Bethesda, United States
5 h-index
41 publications
7.3K citations
University of California, Los Angeles
Los Angeles, United States
5 h-index
19 publications
5.4K citations
1–8 of 438
Repository · 39 publications · 1.9K citations
18
h-index
15 publications · 883 citations
14
h-index
13 publications · 788 citations
12
h-index
8 publications · 393 citations
8
h-index
CID · 5 publications · 451 citations
6
h-index
1–5